Trial Profile
A Study to Evaluate the Efficacy and Safety of Telaprevir-based Triple Therapy in HIV (Human Immunodeficiency Virus)/HCV (Hepatitis C Virus) Coinfected versus HCV Monoinfected Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 18 Dec 2015 New trial record